We are pleased to announce the launch of COST Action CINNAMON – Connecting an INternational Network of Academic Manufacturers of ONcoimmunotherapies.

🧬 The initiative aims to promote access to the advanced CAR-T therapies, transforming cancer care.

👉 Learn more: https://loom.ly/La5ZzY8

💡 How can we improve patient access to advanced therapies and personalised medicine?

David Morrow, explains how EATRIS and PRECISEU are leading the way in connecting regional hubs across Europe to address regulatory challenges and map capacity.

👉 Read more here: https://loom.ly/87v3K8k

Launch of COST Action INFLAMomx – Pan-European Network for Inflamm-ageing: A Multi-omics Integration Approach.

🔬 The project aims to build a framework for studying age-related disease mechanisms and informing preventive care models.

🔗 More information here: https://eatris.eu/inflamomx/

#EATRISMeets features Dr M. Carolina Florian (IDIBELL), whose new Nature Aging paper reveals a promising strategy to restore ageing blood #StemCells. Her work shows the power of #TranslationalResearch for healthier ageing.
👉 See the interview: https://eatris.eu/eatris-meets/maria-carolina-florian

🇳🇴🇸🇪🇫🇮 The final Bridging Nordic ATMP webinar of 2025 is on 3 Dec with Erja Kerkelä from the Finnish Red Cross Blood Service, who will speak on building #ATMP capabilities in a non-profit setting — drawing on 20+ years of experience in #CellTherapy & GMP development.
👉 https://loom.ly/cKcWiM0

🇵🇹 As part of the EATRIS Portugal Spotlight Programme, we’re featuring the people behind #EATRIS_PT. Dr Rui Santos Ivo, President of INFARMED and key leader in EU health regulation, shares his insights.

👉 Read the full interview here: https://eatris.eu/eatris-meets/rui-santos-ivo